371 related articles for article (PubMed ID: 9521341)
1. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention.
Motwani JG; Topol EJ
Circulation; 1998 Mar; 97(9):916-31. PubMed ID: 9521341
[TBL] [Abstract][Full Text] [Related]
2. The future of saphenous vein as a coronary artery bypass conduit.
Angelini GD; Newby AC
Eur Heart J; 1989 Mar; 10(3):273-80. PubMed ID: 2565234
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms, Prevention and Treatment of Saphenous Vein Graft Disease.
Wolny R; Mintz GS; Pręgowski J; Witkowski A
Am J Cardiol; 2021 Sep; 154():41-47. PubMed ID: 34256942
[TBL] [Abstract][Full Text] [Related]
4. Arterial and venous conduits for coronary artery bypass. A current review.
Cooper GJ; Underwood MJ; Deverall PB
Eur J Cardiothorac Surg; 1996; 10(2):129-40. PubMed ID: 8664004
[TBL] [Abstract][Full Text] [Related]
5. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.
Harskamp RE; Lopes RD; Baisden CE; de Winter RJ; Alexander JH
Ann Surg; 2013 May; 257(5):824-33. PubMed ID: 23574989
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis after coronary artery bypass surgery: results of recent studies and recommendations regarding prevention.
Bourassa MG; Campeau L; Lespérance J; Solymoss BC
Cardiology; 1986; 73(4-5):259-68. PubMed ID: 3530460
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of aortocoronary saphenous vein bypass graft disease.
Hassantash SA; Bikdeli B; Kalantarian S; Sadeghian M; Afshar H
Asian Cardiovasc Thorac Ann; 2008 Aug; 16(4):331-6. PubMed ID: 18670032
[TBL] [Abstract][Full Text] [Related]
9. The pathology of surgically excised aortocoronary saphenous vein bypass grafts.
Kern WH; Wells WJ; Meyer BW
Am J Surg Pathol; 1981 Jul; 5(5):491-6. PubMed ID: 6974507
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
Shukla N; Jeremy JY
Curr Opin Pharmacol; 2012 Apr; 12(2):114-20. PubMed ID: 22321569
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy in the coronary vein graft patient.
Israel DH; Adams PC; Stein B; Chesebro JH; Fuster V
Clin Cardiol; 1991 Apr; 14(4):283-95. PubMed ID: 2032405
[TBL] [Abstract][Full Text] [Related]
12. Preoperative factors predicting saphenous vein graft occlusion in coronary artery bypass grafting: a multivariate analysis.
Malinska A; Podemska Z; Perek B; Jemielity M; Buczkowski P; Grzymislawska M; Sujka-Kordowska P; Nowicki M
Histochem Cell Biol; 2017 Oct; 148(4):417-424. PubMed ID: 28478589
[TBL] [Abstract][Full Text] [Related]
13. Comparison of composition of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary arteries in the same men.
Mautner SL; Mautner GC; Hunsberger SA; Roberts WC
Am J Cardiol; 1992 Dec; 70(18):1380-7. PubMed ID: 1442604
[TBL] [Abstract][Full Text] [Related]
14. Cardiac saphenous vein bypass graft disease.
Lau GT; Lowe HC; Kritharides L
Semin Vasc Med; 2004 May; 4(2):153-9. PubMed ID: 15478036
[TBL] [Abstract][Full Text] [Related]
15. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors.
Solymoss BC; Nadeau P; Millette D; Campeau L
Circulation; 1988 Sep; 78(3 Pt 2):I140-3. PubMed ID: 3261650
[TBL] [Abstract][Full Text] [Related]
16. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenic protein-4: a potential novel target for preventing vein graft failure in coronary revascularization.
Hu J; Zhao JJ
Med Hypotheses; 2013 Dec; 81(6):1025-8. PubMed ID: 24119764
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy to prevent occlusion of venous bypass grafts.
Bhardwaj S; Roy H; Ylä-Herttuala S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):641-52. PubMed ID: 18510482
[TBL] [Abstract][Full Text] [Related]
19. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
20. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses.
Butany JW; David TE; Ojha M
Can J Cardiol; 1998 May; 14(5):671-7. PubMed ID: 9627522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
